Lexaria Bioscience Corp.

NasdaqCM:LEXX Stock Report

Market Cap: US$20.7m

Lexaria Bioscience Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:LEXX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
03 Dec 24BuyUS$67,175Richard ChristopherIndividual27,172US$2.47
02 Dec 24BuyUS$51,217Richard ChristopherIndividual22,828US$2.24
31 Aug 24BuyUS$322,428Wayne BoosIndividual113,531US$2.84
31 Aug 24SellUS$1,691,293Wayne BoosIndividual533,531US$3.17
12 Aug 24BuyUS$5,008Catherine TurkelIndividual1,600US$3.13
31 Jul 24BuyUS$391,162Wayne BoosIndividual137,733US$2.84
31 Jul 24SellUS$10,268Vanessa CarleIndividual2,567US$4.00
31 Jul 24SellUS$751,155Wayne BoosIndividual242,308US$3.10

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of LEXX?
Owner TypeNumber of SharesOwnership Percentage
Private Companies308,4871.76%
Institutions1,459,4528.31%
Individual Insiders1,554,0508.85%
General Public14,237,19081.1%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 36.3%.

Top Shareholders

Top 25 shareholders own 18.77% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
3.42%
Wayne Boos
600,000US$708.0k0%no data
2.67%
Don Jackler
468,382US$552.7k0%no data
2.62%
Armistice Capital LLC
460,000US$542.8k-54.9%0.01%
2.34%
Invenomic Capital Management LP
410,731US$484.7k-13.7%0.05%
2.13%
Christopher Bunka
373,543US$440.8k36.6%no data
1.45%
CAB Financial Services Ltd.
254,412US$300.2k0%no data
0.95%
Geode Capital Management, LLC
166,679US$196.7k10.8%no data
0.73%
The Vanguard Group, Inc.
127,433US$150.4k16.9%no data
0.35%
Raymond James Financial Inc., Asset Management Arm
60,640US$71.6k0%no data
0.31%
Docherty Management Ltd.
54,075US$63.8k0%no data
0.28%
Richard Christopher
50,000US$59.0k0%no data
0.22%
State Street Global Advisors, Inc.
39,301US$46.4k0%no data
0.18%
Wealth Enhancement Advisory Services, LLC
30,959US$36.5k7.22%no data
0.16%
Byrne Asset Management, LLC
28,905US$34.1k122%0.03%
0.16%
BlackRock, Inc.
27,445US$32.4k0%no data
0.12%
HighTower Advisors, LLC
21,023US$24.8k61.4%no data
0.12%
Morgan Stanley, Investment Banking and Brokerage Investments
20,229US$23.9k-12%no data
0.1%
Northern Trust Global Investments
18,389US$21.7k0%no data
0.08%
BMO Asset Management Corp.
14,000US$16.5k0%no data
0.075%
William McKechnie
13,191US$15.6k0%no data
0.074%
Baljinder Bhullar
13,000US$15.3k0%no data
0.063%
Nicholas Baxter
11,000US$13.0k0%no data
0.062%
Albert Reese
10,917US$12.9k0%no data
0.062%
Al Rees
10,917US$12.9k0%no data
0.057%
Scotiabank Global Banking and Markets, Asset Management Division
10,000US$11.8k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/01 18:01
End of Day Share Price 2025/04/30 00:00
Earnings2025/02/28
Annual Earnings2024/08/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Lexaria Bioscience Corp. is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ammar ShahEight Capital
Yi ChenH.C. Wainwright & Co.
Jason McCarthyMaxim Group